209 related articles for article (PubMed ID: 32630402)
1. Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment-Drug Conjugates.
Kim EG; Jeong J; Lee J; Jung H; Kim M; Zhao Y; Yi EC; Kim KM
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32630402
[TBL] [Abstract][Full Text] [Related]
2. The influence of antibody fragment format on phage display based affinity maturation of IgG.
Steinwand M; Droste P; Frenzel A; Hust M; Dübel S; Schirrmann T
MAbs; 2014; 6(1):204-18. PubMed ID: 24262918
[TBL] [Abstract][Full Text] [Related]
3. Shelf-Life Extension of Fc-Fused Single Chain Fragment Variable Antibodies by Lyophilization.
Schneider KT; Kirmann T; Wenzel EV; Grosch JH; Polten S; Meier D; Becker M; Matejtschuk P; Hust M; Russo G; Dübel S
Front Cell Infect Microbiol; 2021; 11():717689. PubMed ID: 34869052
[TBL] [Abstract][Full Text] [Related]
4. A fully human scFv phage display library for rapid antibody fragment reformatting.
Li K; Zettlitz KA; Lipianskaya J; Zhou Y; Marks JD; Mallick P; Reiter RE; Wu AM
Protein Eng Des Sel; 2015 Oct; 28(10):307-16. PubMed ID: 25991864
[TBL] [Abstract][Full Text] [Related]
5. Construction of Human Immune and Naive scFv Libraries.
Kügler J; Tomszak F; Frenzel A; Hust M
Methods Mol Biol; 2018; 1701():3-24. PubMed ID: 29116497
[TBL] [Abstract][Full Text] [Related]
6. Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display.
Keller T; Kalt R; Raab I; Schachner H; Mayrhofer C; Kerjaschki D; Hantusch B
PLoS One; 2015; 10(5):e0127169. PubMed ID: 25993332
[TBL] [Abstract][Full Text] [Related]
7. Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment-Drug Conjugates (FDCs).
Jolivet L; Ait Mohamed Amar I; Horiot C; Boursin F; Colas C; Letast S; Denevault-Sabourin C; Allard-Vannier E; Joubert N; Aubrey N
Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893780
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
9. Reformatting of scFv antibodies into the scFv-Fc format and their downstream purification.
Bujak E; Matasci M; Neri D; Wulhfard S
Methods Mol Biol; 2014; 1131():315-34. PubMed ID: 24515475
[TBL] [Abstract][Full Text] [Related]
10. Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies.
Ten Haaf A; Pscherer S; Fries K; Barth S; Gattenlöhner S; Tur MK
Immunol Lett; 2015 Aug; 166(2):65-78. PubMed ID: 26045318
[TBL] [Abstract][Full Text] [Related]
11. Internalization of CD239 highly expressed in breast cancer cells: a potential antigen for antibody-drug conjugates.
Kikkawa Y; Enomoto-Okawa Y; Fujiyama A; Fukuhara T; Harashima N; Sugawara Y; Negishi Y; Katagiri F; Hozumi K; Nomizu M; Ito Y
Sci Rep; 2018 Apr; 8(1):6612. PubMed ID: 29700410
[TBL] [Abstract][Full Text] [Related]
12. Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro.
Aubrey N; Allard-Vannier E; Martin C; Bryden F; Letast S; Colas C; Lakhrif Z; Collinet N; Dimier-Poisson I; Chourpa I; Viaud-Massuard MC; Joubert N
Bioconjug Chem; 2018 Nov; 29(11):3516-3521. PubMed ID: 30352511
[TBL] [Abstract][Full Text] [Related]
13. Selection of tumor-specific internalizing human antibodies from phage libraries.
Poul MA; Becerril B; Nielsen UB; Morisson P; Marks JD
J Mol Biol; 2000 Sep; 301(5):1149-61. PubMed ID: 10966812
[TBL] [Abstract][Full Text] [Related]
14. Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells.
Kalinovsky DV; Kholodenko IV; Kibardin AV; Doronin II; Svirshchevskaya EV; Ryazantsev DY; Konovalova MV; Rozov FN; Larin SS; Deyev SM; Kholodenko RV
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674755
[TBL] [Abstract][Full Text] [Related]
15. Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models.
Kuo WY; Hsu HJ; Wu CY; Chen HS; Chou YC; Tsou YL; Peng HP; Jian JW; Yu CM; Chiu YK; Chen IC; Tung CP; Hsiao M; Lin CL; Wang YA; Wang AH; Yang AS
MAbs; 2019 Jan; 11(1):153-165. PubMed ID: 30365359
[TBL] [Abstract][Full Text] [Related]
16. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
[TBL] [Abstract][Full Text] [Related]
17. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
18. High throughput cytotoxicity screening of anti-HER2 immunotoxins conjugated with antibody fragments from phage-displayed synthetic antibody libraries.
Hou SC; Chen HS; Lin HW; Chao WT; Chen YS; Fu CY; Yu CM; Huang KF; Wang AH; Yang AS
Sci Rep; 2016 Aug; 6():31878. PubMed ID: 27550798
[TBL] [Abstract][Full Text] [Related]
19. Selecting an optimal antibody for antibody-drug conjugate therapy: internalization and intracellular localization.
Harper J; Mao S; Strout P; Kamal A
Methods Mol Biol; 2013; 1045():41-9. PubMed ID: 23913140
[TBL] [Abstract][Full Text] [Related]
20. Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs.
Forte N; Livanos M; Miranda E; Morais M; Yang X; Rajkumar VS; Chester KA; Chudasama V; Baker JR
Bioconjug Chem; 2018 Feb; 29(2):486-492. PubMed ID: 29384367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
